🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
This phase II trial studies olaparib and temozolomide in treating patients ...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2019-08-19
Trial ID
NCT03880019
Treatments Being Tested
This is a Phase II, non-randomized, open-label study to evaluate temozolomi...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2020-06-17
Trial ID
NCT04166435
Treatments Being Tested
RATIONALE: Olaparib may stop the growth of tumor cells by blocking some of ...
Status
Completed
Location
Bristol Haematology and Oncology Centre
Start Date
2011-07
Trial ID
NCT01390571
This research study is a Three arm Phase I clinical trial, which tests the ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-07-01
Trial ID
NCT01858168
Treatments Being Tested
The main purpose of this study is to explore the feasibility of selecting t...
Status
Recruiting
Location
Tianjin Medical Unversity Second Hospital
Start Date
2024-11-01
Trial ID
NCT06739395
This study will test the safety and effectiveness of a combination of pembr...
Status
Recruiting
Location
Hartford Healthcare Alliance (Data Collection Only)
Start Date
2022-01-14
Trial ID
NCT05188508
Treatments Being Tested
This proof-of-concept platform trial is designed to cover the targeting of ...
Status
Recruiting
Location
Rigshospitalet
Start Date
2016-08-03
Trial ID
NCT02813135
This is a randomized phase II study to evaluate the disease control rate (D...
Status
Not Yet Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
Start Date
2026-04-01
Trial ID
NCT05128734
Treatments Being Tested
This phase II trial studies how well the addition of olaparib to the usual ...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2021-03-17
Trial ID
NCT04394858